Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Arzerra (ofatumumab)
pCPA File Number:
20803
Negotiation Status:
Negotiations were not pursued
Indication(s):
Chronic Lymphocytic Leukemia
Sponsor/Manufacturer:
GlaxoSmithKline
CADTH Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
2015-02-27